Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
about
Cancer stem cells and signaling pathways in radioresistanceTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyThe miR-99 family regulates the DNA damage response through its target SNF2HMechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEKRac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomicsProteomics of cancer stem cells.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cellsMethylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.Protein expression of nucleophosmin, annexin A3 and nm23-H1 correlates with human nasopharyngeal carcinoma radioresistance in vivo.Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.Challenges in cancer research and multifaceted approaches for cancer biomarker quest.Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.Targeting inflammatory pathways for tumor radiosensitization.RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cellsDifferential proteomics in the search for biomarkers of radiotherapy resistance.The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology.Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes.The role of inflammatory pathways in cancer-associated cachexia and radiation resistance.Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.Isogenic radiation resistant cell lines: development and validation strategies.Cancer biomarker discovery: current status and future perspectives.Putative biomarkers and therapeutic targets associated with radiation resistance.CXCR4 as biomarker for radioresistant cancer stem cells.Digital gene expression profiling analysis of DNA repair pathways in colon cancer stem population of HT29 cells.Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.Mitochondrial KATP Channels Control Glioma Radioresistance by Regulating ROS-Induced ERK Activation.Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.Long-term recovery of irradiated prostate cancer increases cancer stem cells.Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells.Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity.Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancerEpithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells.Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
P2860
Q26771576-17355E2D-AFA1-4B65-97F6-76BA2D92AB80Q26777016-B5A4F8B6-68CA-4DEA-8964-ED8BACBBFAC2Q30417554-A1577888-105F-4D1E-A6D5-957EFF3D12C7Q33562476-74825463-315A-4EC2-A938-AE205D868E81Q33682966-3D2CB791-1331-4EBB-9A42-FECC82735E6DQ34438608-19AB983A-39A3-477B-AE56-87A6218C7F37Q34855520-5EDBDD69-B56D-4790-9C98-91CE5DD1D512Q35071416-92040192-357E-45A9-BC0D-73BB3655A4CBQ35287094-EF99A85B-DC71-4EC6-97D0-613417AEAABDQ35579329-713C91BB-BF2B-447D-A7E4-48948DD0589FQ36213576-05D286E3-2A77-466C-913E-37F10743B844Q37002731-16EB2A75-B82D-42C9-9F98-56660877099CQ37310865-1A8BA548-EF49-4A8F-831E-6210C9E557B6Q37425361-1B084064-26DA-449C-8E51-097881E01279Q37470093-92B094B7-CA46-4731-982C-18FDC4C3C432Q37606662-E4701759-9B47-45C9-BE3D-93585BA4CFF3Q37657753-0B56256E-579F-4661-A273-4B07B3EAA1FEQ37769804-949FEA0E-AD5B-4FDF-BB76-9DA5AAA8893AQ37774686-73463E72-2E8F-4BAC-9C6B-57FFABD4D84FQ37912208-DC4AEF12-393E-4C7B-99DF-F8911A20C45EQ37940376-148241E8-10F2-42E8-991D-23D94DFC77FAQ38081954-156FDF8B-EDCE-432F-BA87-DE15D3E64CB9Q38115997-3FDA9FA6-673F-446A-AD3F-A82713EDEAF4Q38127721-808B3DFC-9E7F-43E4-9860-3C3ED7BD4EAEQ38172298-B5E8B786-2F09-4C11-8CA4-DAEB98899443Q38187679-BF3CC170-9C42-48A0-B320-370CA18B0E13Q38190630-DA4B5D5F-5504-4952-ABC6-9C8582CACCE8Q38197709-6164E2FC-8ED8-4BEE-90F5-CBEBAFD4F352Q38727052-D6B8B851-6C83-4C64-9B10-897E555DB5C4Q38748006-263EBACD-77C0-46F6-89F1-655F3EEE0B7DQ38953888-BFE5DA1B-FF26-4575-B31B-45CB99847A30Q39156783-0547F8C4-7E8E-446D-B4A5-D00C14D7C663Q39249070-BB72DF6F-8B43-493B-99D1-8C59FF98EAAEQ39362645-A5B31906-CF32-4AD5-B574-DFCA274BB005Q39363215-CEFEE788-0B4C-4B8A-B41D-350B3691E046Q41612788-D1375CB8-186E-4427-A687-C486117129A4Q41811530-461A0E79-4971-4EA2-987B-89D755C4DC09Q49456373-37AE24DB-DEB6-4B57-B2A3-B0EEBEC17E13Q50034271-75B2579B-7CF0-4D55-B763-BC514149F6E4Q50482018-AF49EE2A-7E52-4DAA-BC63-7A3CA29620AF
P2860
Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@en
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@nl
type
label
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@en
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@nl
prefLabel
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@en
Intracellular signaling pathwa ...... uman prostate carcinoma cells.
@nl
P2093
P356
P1433
P1476
Intracellular signaling pathwa ...... human prostate carcinoma cells
@en
P2093
Andreas Neher
Bela-Andre Popper
Bernhard Schiestl
Guenther K Bonn
Ira Skvortsova
Peter Lukas
Sergej Skvortsov
Taras Stasyk
P2860
P304
P356
10.1002/PMIC.200800113
P577
2008-11-01T00:00:00Z